Related references
Note: Only part of the references are listed.Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer
S Goodin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
N Vashchenko et al.
EUROPEAN UROLOGY (2005)
Primary and pure neuroendocrine tumor of the prostate
M Freschi et al.
EUROPEAN UROLOGY (2004)
Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma
T Fixemer et al.
PROSTATE (2002)
Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements
G Steineck et al.
ACTA ONCOLOGICA (2002)
Progression of prostate cancer to neuroendocrine cell tumor
M Tanaka et al.
INTERNATIONAL JOURNAL OF UROLOGY (2001)
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma
E Bollito et al.
ANNALS OF ONCOLOGY (2001)
Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization
A Pozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer
A Kumar et al.
BRITISH JOURNAL OF CANCER (2000)
Low PSA metastatic androgen-independent prostate cancer
A Sella et al.
EUROPEAN UROLOGY (2000)